Avzivi® (BAT1706) is Bio-Thera Solutions’ second FDA approved product in the United States Avzivi® is the second biosimilar researched, developed, and manufactured by a Chinese pharmaceutical company to receive FDA approval in the United States GUANGZHOU, China, Dec. 7, 2023 /PRNewswire/…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.